| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
70,591 |
63,409 |
$1.93M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
69,619 |
62,656 |
$1.88M |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
47,888 |
43,545 |
$846K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
20,314 |
19,631 |
$514K |
| 83655 |
|
48,897 |
44,658 |
$472K |
| 86780 |
|
37,237 |
34,023 |
$373K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,936 |
3,925 |
$285K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,753 |
2,530 |
$122K |
| 86592 |
|
1,026 |
922 |
$3K |
| 86803 |
|
209 |
206 |
$2K |